6 research outputs found
Automatic Sleep EEG Pattern Detection
Analýza mozkové aktivity je jednou z klícových vyšetrovacích metod v moderní spánkové medicíne a výzkumu.nalysis of recorded brain activity is one of the main investigation methods in modern sleep medicine and research
The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action
Serotonergic agonist psilocybin is a psychedelic with antidepressant potential. Sleep may interact with psilocybin’s antidepressant properties like other antidepressant drugs via induction of neuroplasticity. The main aim of the study was to evaluate the effect of psilocybin on sleep architecture on the night after psilocybin administration. Regarding the potential antidepressant properties, we hypothesized that psilocybin, similar to other classical antidepressants, would reduce rapid eye movement (REM) sleep and prolong REM sleep latency. Moreover, we also hypothesized that psilocybin would promote slow-wave activity (SWA) expression in the first sleep cycle, a marker of sleep-related neuroplasticity. Twenty healthy volunteers (10 women, age 28–53) underwent two drug administration sessions, psilocybin or placebo, in a randomized, double-blinded design. Changes in sleep macrostructure, SWA during the first sleep cycle, whole night EEG spectral power across frequencies in non-rapid eye movement (NREM) and REM sleep, and changes in subjective sleep measures were analyzed. The results revealed prolonged REM sleep latency after psilocybin administration and a trend toward a decrease in overall REM sleep duration. No changes in NREM sleep were observed. Psilocybin did not affect EEG power spectra in NREM or REM sleep when examined across the whole night. However, psilocybin suppressed SWA in the first sleep cycle. No evidence was found for sleep-related neuroplasticity, however, a different dosage, timing, effect on homeostatic regulation of sleep, or other mechanisms related to antidepressant effects may play a role. Overall, this study suggests that potential antidepressant properties of psilocybin might be related to changes in sleep
Objective and Subjective Characteristics of Vigilance under Different Narrow-Bandwidth Light Conditions: Do Shorter Wavelengths Have an Alertness-Enhancing Effect?
An Unsupervised Multichannel Artifact Detection Method for Sleep EEG Based on Riemannian Geometry
International audienceIn biomedical signal processing, we often face the problem of artifacts that distort the original signals. This concerns also sleep recordings, such as EEG. Artifacts may severely affect or even make impossible visual inspection, as well as automatic processing. Many proposed methods concentrate on certain artifact types. Therefore, artifact-free data are often obtained after sequential application of different methods. Moreover, single-channel approaches must be applied to all channels alternately. The aim of this study is to develop a multichannel artifact detection method for multichannel sleep EEG capable of rejecting different artifact types at once. The inspiration for the study is gained from recent advances in the field of Riemannian geometry. The method we propose is tested on real datasets. The performance of the proposed method is measured by comparing detection results with the expert labeling as a reference and evaluated against a simpler method based on Riemannian geometry that has previously been proposed, as well as against the state-of-the-art method FASTER. The obtained results prove the effectiveness of the proposed method
The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action
Recommended from our members
The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.
Serotonergic agonist psilocybin is a psychedelic with antidepressant potential. Sleep may interact with psilocybin's antidepressant properties like other antidepressant drugs via induction of neuroplasticity. The main aim of the study was to evaluate the effect of psilocybin on sleep architecture on the night after psilocybin administration. Regarding the potential antidepressant properties, we hypothesized that psilocybin, similar to other classical antidepressants, would reduce rapid eye movement (REM) sleep and prolong REM sleep latency. Moreover, we also hypothesized that psilocybin would promote slow-wave activity (SWA) expression in the first sleep cycle, a marker of sleep-related neuroplasticity. Twenty healthy volunteers (10 women, age 28-53) underwent two drug administration sessions, psilocybin or placebo, in a randomized, double-blinded design. Changes in sleep macrostructure, SWA during the first sleep cycle, whole night EEG spectral power across frequencies in non-rapid eye movement (NREM) and REM sleep, and changes in subjective sleep measures were analyzed. The results revealed prolonged REM sleep latency after psilocybin administration and a trend toward a decrease in overall REM sleep duration. No changes in NREM sleep were observed. Psilocybin did not affect EEG power spectra in NREM or REM sleep when examined across the whole night. However, psilocybin suppressed SWA in the first sleep cycle. No evidence was found for sleep-related neuroplasticity, however, a different dosage, timing, effect on homeostatic regulation of sleep, or other mechanisms related to antidepressant effects may play a role. Overall, this study suggests that potential antidepressant properties of psilocybin might be related to changes in sleep